The Role of CT and MRI Scans to Diagnose Neurological Conditions

The Role of CT and MRI Scans to Diagnose Neurological Conditions

Dr. Aakaar Kapoor, CEO & Lead Medical Advisor at City X-Ray and Scan Clinic

 Dr. Aakaar Kapoor, CEO & Lead Medical Advisor at City X-Ray and Scan Clinic

Dr. Aakaar Kapoor, MD, is a distinguished Radiologist, Entrepreneur, and CEO at City X-Ray & Scan Clinic, spearheading innovative healthcare solutions. Holding an MD in Radiodiagnosis from KLE University, with an MBBS from UCMS, affiliated with Guru Tegh Bahadur Hospital, Aakaar showcases a wealth of expertise in the medical realm. With a prolific career spanning over 16+ years, he leads a team renowned for pioneering AI-based software and clinical trials in collaboration with multinational corporations.

Neurological disorders pose a formidable challenge in healthcare due to their intricate involvement with the complex nervous system. These conditions stand as the second leading cause of global mortality, accounting for 9.0 million deaths annually, and are the primary cause of disability, attributing to 276 million disability-adjusted life-years (DALYs), with nearly half of this burden affecting low and middle-income countries.

Diagnosing and managing neurological disorders requires acute precision and dedication, considering the complexities of the nervous system. These disorders manifest through structural, biochemical, and electrical abnormalities in the brain, spinal cord, and other nerves, leading to a wide spectrum of symptoms. Studies indicate vulnerability to approximately 600 neurological diseases, including dementia, Alzheimer's, epilepsy, stroke, migraine, Parkinson's disease, multiple sclerosis, brain tumors, neuro-infections, and traumatic disorders like autism and brain trauma.

Diagnostic imaging, particularly Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), plays a pivotal role in evaluating and diagnosing neurological conditions. 

Role of CT scan in neurological conditions

A brain CT scan is a noninvasive diagnostic imaging method that utilizes specialized X-ray measurements to generate images or slices of the brain. This imaging technique provides more comprehensive details about brain tissue excelling in detailed bone visualization, particularly in the posterior fossa, base of the skull, and spinal canal, an advantage over Magnetic Resonance Imaging (MRI).

Noncontrast CT swiftly identifies acute hemorrhage and significant structural alterations without the concern of contrast-related issues like allergy or renal failure. Using a radiopaque contrast agent, CT efficiently detects abnormal structural lesions such as brain tumors, abscesses, and certain vascular anomalies like arteriovenous malformations. Although rarely used due to MRI availability, an intrathecal agent assists in outlining abnormalities affecting the brain stem, spinal cord, or spinal nerve roots, potentially identifying conditions like meningeal carcinoma or herniated disks, and occasionally revealing a syrinx in the spinal cord. Furthermore, CT angiography, facilitated by contrast agents, effectively portrays cerebral blood vessels, negating the necessity for MRI or traditional angiography procedures.

Role of MRI

In contrast to CT, Magnetic Resonance Imaging (MRI) offers superior resolution when visualizing neural structures, particularly benefiting the examination of cranial nerves, brain stem lesions, and anomalies in the posterior fossa and spinal cord. It serves various neurological purposes, including the diagnosis of brain and spinal cord tumors, eye conditions, inflammation, infections, and vascular irregularities that may precipitate a stroke.

MRI is adept at detecting and monitoring degenerative disorders like multiple sclerosis and can accurately depict brain injuries resulting from trauma. Its advanced capabilities shine in identifying spinal cord compression caused by tumors or abscesses necessitating immediate intervention. Additionally, MRI excels in identifying demyelinating plaques, early signs of infarction, cerebral edema, and various other conditions that can be challenging to visualize using CT imaging.

While the two have their own set of advantages, limitations also persist. In areas due to bony streaks in the brain stem and spinal cord, CT images may show as artifacts, on the other hand, MRI provides clearer images in these regions. Furthermore, the choice between the two often depends on the clinical context, specific indications, and urgency as each of them has its strengths and limitations in visualizing different aspects of neurological conditions.

Choosing between the two - MRI Vs. CT 

When comparing MRI scans to CT scans for brain imaging, MRI emerges as the most sensitive and preferred technique, especially concerning brain examinations, due to its superior imaging capabilities. 

Notably, MRI is particularly adept at detecting brain tumors owing to its heightened sensitivity. However, CT scans also offer distinct advantages in brain imaging. CT scans excel in speed, making them the preferred choice in cases of acute neurological emergencies or trauma. Additionally, they are more cost-effective and can effectively rule out various neurological disorders. Their faster imaging process makes them less sensitive to patient motion, suitable for individuals who struggle with remaining still during the examination. Moreover, CT scans are often favored for patients who are claustrophobic or have larger body builds, as they do not require entry into a confined space like an MRI machine. They provide detailed evaluations of cortical bone, aiding in the assessment of bone structures and potential fractures, and offer accurate detection of calcifications and metal foreign bodies within the brain. Furthermore, CT scans can be safely conducted on patients with implantable medical devices. In contrast, MRI scans present unique advantages in brain imaging as well.

They are considered safer as they do not utilize ionizing radiation, making them preferable, particularly for children and individuals requiring multiple imaging examinations. MRI's superior soft tissue contrast enables detailed visualization of brain anatomy, ensuring heightened sensitivity and specificity in identifying brain abnormalities. The flexibility of multi-plane imaging in MRI allows for imaging in various planes without physically moving the patient, offering comprehensive visualization of brain structures. Additionally, the lower risk of allergic reactions associated with MRI contrast agents is noteworthy compared to other imaging modalities. Moreover, MRI allows artifact-free evaluation of structures, enhancing the accuracy and clarity of diagnostic information, which might otherwise be obscured by bone artifacts in CT images.

In summation, CT and MRI scans are indispensable tools in diagnosing and managing neurological disorders, offering complementary advantages in visualizing structural abnormalities and neural structures. Understanding the strengths and limitations of each imaging modality is crucial for healthcare professionals to ensure accurate diagnosis and effective treatment planning for patients with neurological conditions.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.